DCGO.NASDAQDocgo INC
10-Q: DocGo Q3 2025: Revenue Plummets Amid Migrant Contract Wind-Down
Sentiment:
Quarterly Report
DocGo Inc. reported a significant net loss and revenue decline in Q3 2025, primarily due to the wind-down of large migrant-related services, despite growth in its Transportation Services segment.
Capital raiseThe company might need to, or choose to, raise additional capital through debt or equity financings if its growth rate is higher than currently anticipated, resulting in greater-than-anticipated capital requirements.The acquisition of SteadyMD, Inc. includes up to an additional $12.5 million in deferred consideration, payable in cash or equity at the company's election, indicating a potential future equity issuance.
Worse than expectedTotal revenues decreased by 49.0% in Q3 2025 and 50.1% for the nine months ended September 30, 2025, primarily due to the significant wind-down of migrant-related services.The company reported a net loss of $29.7 million in Q3 2025 and $54.0 million for the nine months ended September 30, 2025, a substantial deterioration from net income in the prior year periods.Operating expenses increased by 51.0% in Q3 2025, and cost of revenues as a percentage of revenue increased, indicating significant margin compression.Significant non-cash impairment charges totaling $16.7 million were recognized for goodwill and intangible assets in Q3 2025, reflecting a downward revision in financial outlook for a key segment.
Summary
- Net loss of $29.7 million for the three months ended September 30, 2025, a significant decline from net income of $4.5 million in the prior year period.
- Total revenues decreased by 49.0% to $70.8 million in Q3 2025 from $138.7 million in Q3 2024.
- Mobile Health Services revenue plummeted by 77.2% to $20.7 million, primarily due to the ongoing wind-down of migrant-related services.
- Transportation Services revenue increased by 4.4% to $50.1 million, driven by a 2.5% rise in U.S. trip volumes and an increase in average trip price to $411.
- Operating expenses increased by 51.0% to $60.1 million, including $16.7 million in non-cash impairment charges for goodwill and finite-lived intangible assets related to the Mobile Health Services segment.
- Net cash provided by operating activities decreased by 21.8% to $44.9 million for the nine months ended September 30, 2025.
- Acquired Professional Technicians, LLC (mobile phlebotomy services) in February 2025 and SteadyMD, Inc. (telehealth services) in October 2025.
- Repaid $30.0 million outstanding on the Prior Revolving Facility in August 2025 and entered into a new Revolving Facility of up to $55.0 million with no outstanding borrowings as of September 30, 2025.
Sentiment
Score: 3
Explanation: The company experienced a substantial decline in revenue and a significant net loss, driven by the wind-down of major contracts and substantial impairment charges. While the Transportation Services segment showed some growth and accounts receivable collections improved, the overall financial performance is severely impacted, indicating significant operational challenges and a negative short-term outlook. Strategic acquisitions and cost-containment efforts are underway, but their impact is yet to fully materialize.
Positives
- Transportation Services revenue increased by 4.4% to $50.1 million in Q3 2025, with U.S. trip volumes up 2.5% and average trip price rising to $411.
- Net cash provided by operating activities was $44.9 million for the nine months ended September 30, 2025, despite a net loss, indicating some operational cash generation.
- Successful collection of older invoices from large municipal customers led to a $100.7 million decrease in accounts receivable for the nine months ended September 30, 2025.
- Repaid $30.0 million outstanding on the Prior Revolving Facility in August 2025, and the new Revolving Facility has no outstanding borrowings, improving the debt position.
- Acquisition of SteadyMD, Inc. in October 2025 is expected to enhance Mobile Health Services with a 50-state virtual clinician workforce and clinical operations.
Negatives
- Net loss of $29.7 million in Q3 2025, a significant deterioration from net income of $4.5 million in Q3 2024.
- Total revenues decreased by 49.0% in Q3 2025 and 50.1% for the nine months ended September 30, 2025, primarily due to a 77.2% drop in Mobile Health Services revenue.
- Recognized $8.7 million goodwill impairment and $8.0 million finite-lived intangible asset impairment in Q3 2025, primarily related to the Rapid Temps reporting unit within Mobile Health Services.
- Cost of revenues as a percentage of revenue increased to 74.4% in Q3 2025 from 64.0% in Q3 2024, indicating margin compression.
- Operating expenses increased by 51.0% in Q3 2025, and as a percentage of revenue, rose to 84.9% from 28.7% in the prior year period.
- Net loss attributable to noncontrolling interests increased to $1.9 million in Q3 2025 from $1.0 million in Q3 2024.
- Cash and cash equivalents decreased by $15.9 million from December 31, 2024, to September 30, 2025.
- Net cash used in investing activities significantly increased to $26.0 million for the nine months ended September 30, 2025, from $5.2 million in the prior year, partly due to restricted investment purchases.
- Net cash used in financing activities significantly increased to $48.9 million for the nine months ended September 30, 2025, from $16.3 million in the prior year, due to debt repayment and share repurchases.
Risks
- Sustained reduction of revenue and forecasts in the Mobile Health Services operating segment, leading to significant impairment charges.
- High dependence on government contracts, which are expected to decline significantly due to the ending of large migrant-related projects in New York, potentially impacting future revenues.
- Government contract work subjects the company to audits, investigations, and proceedings, which could lead to being barred from government work or subjected to fines.
- A shift in government policies or priorities regarding healthcare spending could have a material adverse effect on revenues.
- Concentration of credit risk with two customers accounting for approximately 21% and 19% of net accounts receivable as of September 30, 2025, and 19% and 11% of Q3 2025 revenues.
- Inflationary pressures on wages, fuel, and medical supplies could continue to compress gross profit margins, as the company is generally unable to pass these higher costs on to customers.
- Emerging uncertainty around municipal budgets, including the healthcare segment, could impact the public sector portion of the Mobile Health Services market.
- Inability to expand programs with insurance partners, hospital systems, municipalities, and other strategic partners could hinder future growth.
- Failure to innovate and enhance products and services could adversely affect market position and revenue.
- Ongoing legal proceedings, including California Labor Actions and Stockholder Actions, pose potential financial and reputational risks, with outcomes still uncertain for some cases.
Future Outlook
The company expects overall Mobile Health Services revenues to be lower in 2026 due to the absence of migrant-related project revenues, despite anticipated growth in other business lines within the segment. It also expects general and administrative costs to decline sequentially in absolute dollar terms but increase as a percentage of revenues over the remainder of 2025. Over the longer term, general and administrative expenses are expected to increase along with headcount as overall business activity increases, including higher sales and marketing fees and investments in technology and AI. The company anticipates that existing cash, future operating cash flows, and amounts available under the Revolving Facility will be sufficient to meet operating requirements for at least the next twelve months and beyond, with potential additional financings to satisfy any operating and potential investing requirements.
Management Comments
- "We expect that overall Mobile Health Services revenues will be lower in 2026 than they were in 2025, given the absence of migrant-related project revenues."
- "We anticipate that operating expenses will decline as certain ongoing cost-containment efforts take hold."
- "We expect technology and development expenses to increase in future periods to support our growth, including our intent to continue investing in the optimization, accuracy and reliability of our dispatch and communication platform and driving efficiency in our operations."
- "We expect our sales, advertising and marketing expenses to continue to increase over time as we increase our marketing activities, expand into new geographic markets and customer verticals, particularly in the Mobile Health segment, and continue to build brand awareness."
- "We anticipate that its existing balances of cash and cash equivalents, future expected cash flows generated from its operations and amounts available under the Revolving Facility will be sufficient to satisfy operating requirements for at least the next twelve months."
Industry Context
The Mobile Health Services market is influenced by patient acceptance of non-traditional care settings, healthcare coverage, and government funding for population health programs. Emerging uncertainty in municipal budgets could impact the public sector portion. The Transportation Services market is driven by chronic conditions, elective surgeries, and an aging population, with potential growth from hospitals outsourcing transport. The company's strategy to reduce reliance on subcontractors in Transportation Services aligns with efforts to control labor costs, a key industry expense. The acquisition of SteadyMD reflects a broader industry trend towards virtual care and telehealth expansion, positioning the company to capitalize on evolving healthcare delivery models.
Comparison to Industry Standards
- NA
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Executive Officer | Anthony Capone | NA | September 15, 2023 | Resigned, entered into separation and transition services agreement. |
| Director and Chair of the Board | Stan Vashovsky | NA | March 31, 2024 | Retired, entered into separation and consulting agreement. |
| Director and Independent Chair of the Board of Directors | Steven Katz | NA | October 1, 2024 | Resigned, entered into transition consulting agreement. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Share Repurchase Program Extension | Board extended the expiration date of the New Repurchase Program from June 30, 2025, to December 31, 2025. | June 12, 2025 | Allows for continued discretionary share repurchases, potentially influencing stock price and shareholder value. |
| Credit Agreement Amendment | Amended and restated the Prior Credit Agreement, establishing a new Revolving Facility of up to $55.0 million, subject to a minimum liquidity financial covenant. | August 7, 2025 | Adjusts the company's debt structure and liquidity management, introducing a new financial covenant. |
Legal Proceedings
- California Labor Actions: A settlement in principle has been reached for various wage and hour claims and PAGA actions, with a preliminary approval hearing set for February 6, 2026.
- Stockholder Actions: An agreement to settle the federal securities class action has been reached, subject to district court approval. Two derivative actions in Delaware have been consolidated, with a motion to dismiss due to be fully briefed in January 2026. A third derivative action in New York is stayed pending a Board committee's review of a litigation demand.
- Cybersecurity Action: The settlement for a data security incident was finally approved by the court on August 22, 2025, with the total cost expected to be covered by cybersecurity insurance.
Related Party Transactions
- Legal Services: Payments to Ely D. Tendler Strategic & Legal Services PLLC, a law firm owned by the General Counsel and Secretary Ely D. Tendler, totaled $323,735 for Q3 2025 and $891,280 for 9M 2025.
- Subcontractor Services: Payments to PrideStaff, owned by a former operations manager and spouse, totaled $500 for Q3 2025 and $56,819 for 9M 2025.
- Transition Services Agreement (Anthony Capone): No payments were made in Q3 2025 or 9M 2025, but $180,000 was paid in 9M 2024 for consulting services after his resignation as CEO.
- Consulting Agreement (Stan Vashovsky): No RSUs were granted in Q3 2025, but $35,000 in RSUs were granted for 9M 2025 for advisory services after his retirement as Director and Chair.
- Transition Consulting Agreement (Steven Katz): No payments were made in Q3 2025, but $2,500 was paid for 9M 2025 for transition advisory services after his resignation as Director and Independent Chair.
Stakeholder Impact
- Shareholders: Negative impact due to significant net loss, substantial revenue decline, and impairment charges. The share repurchase program aims to return value, but stock price volatility and ongoing legal proceedings (stockholder actions) remain concerns.
- Employees: Increased field headcount and temporary wage increases in the Transportation Services segment, but overall compensation costs decreased in Mobile Health Services due to the wind-down of projects. Stock-based compensation remains a significant component of overall compensation.
- Customers: Mobile Health Services customers, particularly municipalities, are experiencing the wind-down of migrant-related projects. Transportation Services customers are seeing increased trip volumes. New acquisitions like SteadyMD aim to enhance future service offerings and expand capabilities.
- Suppliers: One major vendor accounted for 11% of total cost in Q3 2025, indicating some concentration risk. The company believes alternative sources are available.
- Creditors: Repayment of the Prior Revolving Facility and establishment of a new facility demonstrate active debt management. The new Revolving Facility includes a minimum liquidity financial covenant, which is relevant for creditors.
Next Steps
- Finalize settlement for California Labor Actions, with a preliminary approval hearing set for February 6, 2026.
- Seek court approval for the settlement of the federal securities class action.
- Defendants to fully brief motion to dismiss consolidated derivative actions by January 2026.
- Board committee to continue review of Jung Jae Hyung's litigation demand.
- Administrator to calculate allowable claims for the Cybersecurity Action settlement.
- Integrate SteadyMD, Inc. into the Mobile Health Services operating segment.
- Continue to bid on government contracts, despite expected decline in migrant-related work.
- Implement ongoing cost-containment efforts to reduce operating expenses.
- Continue investing in R&D, including optimization of dispatch and communication platform and new areas like AI.
- Increase marketing activities and expand into new geographic markets and customer verticals, particularly in Mobile Health.
- Evaluate the impact of adopting new accounting standards: ASU 2023-09 (Income Tax Disclosures), ASU 2024-03 (Expense Disaggregation Disclosures), ASU 2025-03 (Determining Accounting Acquirer in VIEs), and ASU 2025-06 (Internal-Use Software).
Key Dates
| Date | Description |
|---|---|
| January 1, 2019 | Company adopted ASC 606, Revenue from Contracts with Customers, and ASC 842, Leases. |
| October 26, 2021 | Company acquired a 50% interest in RND Health Services Inc. |
| November 1, 2021 | Company acquired a 20% interest in National Providers Association, LLC (NPA). |
| November 5, 2021 | DocGo Inc. consummated business combination with Ambulnz, Inc. and changed its name from Motion Acquisition Corp. |
| January 2022 | Company established a 401(k) plan. |
| July 13, 2022 | Holdings acquired 100% of Exceptional Medical Transportation, LLC. |
| August 9, 2022 | Holdings acquired 100% of Ryan Bros. Fort Atkinson, LLC. |
| November 1, 2022 | Company entered into the Prior Credit Agreement for a revolving credit facility. |
| December 9, 2022 | Holdings, through its indirect wholly owned subsidiary Ambulnz U.K. Ltd., acquired 100% of Location Medical Services, LLC (LMS). |
| March 30, 2023 | Paul Lowe v. Rapid Reliable Testing, LLC, et al. (California Labor Action) filed. |
| March 31, 2023 | Holdings acquired 51% of Cardiac RMS, LLC (CRMS). |
| October 11, 2023 | Company and Anthony Capone entered into a separation and transition services agreement. |
| October 20, 2023 | Company obtained an unconditional and irrevocable letter of credit for $1,080,000. |
| October 27, 2023 | Joe Naclerio filed a putative class action complaint for violation of federal securities laws. |
| December 14, 2023 | Corielyn Marie Hall v. Rapid Reliable Testing, LLC, et al. (class complaint) filed. |
| January 17, 2024 | Genesee County Employees Retirement System appointed Lead Plaintiff in securities class action. |
| January 30, 2024 | Board authorized a share repurchase program for up to $36,000,000. |
| February 20, 2024 | Second action by Corielyn Hall (PAGA claims) filed. |
| March 7, 2024 | Company entered into a separation and consulting agreement with Stan Vashovsky. |
| March 18, 2024 | Lead Plaintiff filed an amended complaint in securities class action. |
| April 2, 2024 | Company paid the remaining contingent consideration balance for LMS in the amount of $600,029. |
| May 29, 2024 | Company made a portion of the True-up Payment for CRMS in the amount of $1,000,000. |
| June 21, 2024 | Defendants moved to dismiss the amended complaint in securities class action. |
| July 1, 2024 | Company acquired the remaining noncontrolling interest in Ambulnz CO, LLC. |
| July 19, 2024 | Company issued $1,814,345 in common stock (578,350 shares) for the remainder of the CRMS True-up Payment. |
| August 5, 2024 | Board authorized a new share repurchase program for up to $26,000,000, effectively extending the prior program. |
| August 22, 2024 | Maria Ballesteros filed a complaint against Ambulnz NY, LLC (Cybersecurity Action). |
| September 26, 2024 | Company entered into a transition consulting agreement with Steven Katz. |
| October 1, 2024 | Steven Katz's resignation as a director and independent Chair of the Board of Directors became effective. |
| October 25, 2024 | Company acquired non-marketable equity securities in Firefly Health, Inc. for $5,000,000. |
| November 2024 | FASB issued ASU No. 2024-03, Income Statement Reporting Comprehensive Income Expense Disaggregation Disclosures. |
| December 15, 2024 | Effective date for ASU 2023-09 (Income Tax Disclosures) for fiscal years beginning after this date. |
| December 20, 2024 | Board extended the expiration date of the New Repurchase Program from December 31, 2024, to June 30, 2025. Company obtained an irrevocable letter of credit for $133,303. |
| February 4, 2025 | Company made the final installment payment for the Exceptional Medical Transportation, LLC contingent liability in the amount of $265,538. |
| February 5, 2025 | California Labor Actions mediated concurrently, reaching a settlement in principle. |
| February 10, 2025 | Company acquired 100% of Professional Technicians, LLC (PTI). |
| March 21, 2025 | Plaintiff re-filed the Cybersecurity Action in the Circuit Court of the Eleventh Judicial Circuit of Florida. |
| March 24, 2025 | Plaintiff filed a motion for preliminary approval of the Cybersecurity Action settlement. |
| March 28, 2025 | Motion to dismiss in the securities class action granted in part and denied in part. |
| April 2025 | Company began investing a portion of its restricted cash and cash equivalents into a restricted investment portfolio. |
| April 25, 2025 | Remaining defendants answered the complaint in the securities class action. |
| May 2, 2025 | Court entered an order granting preliminary approval of the Cybersecurity Action settlement. |
| May 13, 2025 | Ryne Shetterly filed a derivative action in the Delaware Court of Chancery. |
| May 2025 | FASB issued ASU No. 2025-03, Business Combinations (Topic 805) and Consolidation (Topic 810): Determining the Accounting Acquirer in the Acquisition of a Variable Interest Entity. |
| June 3, 2025 | Salma Daboul filed a derivative action in the Delaware Court of Chancery. |
| June 12, 2025 | Board further extended the expiration date of the New Repurchase Program from June 30, 2025, to December 31, 2025. |
| July 2025 | The One Big Beautiful Bill Act (OBBBA) was enacted in the U.S. |
| August 1, 2025 | Company repaid all amounts outstanding under the Prior Revolving Facility, totaling $30,320,173. |
| August 5, 2025 | Delaware Court of Chancery consolidated the two derivative actions. |
| August 7, 2025 | Company amended and restated the Prior Credit Agreement to a new Revolving Facility of up to $55.0 million. |
| August 19, 2025 | Jung Jae Hyung filed another derivative complaint in the United States District Court for the Southern District of New York. |
| August 22, 2025 | Final fairness hearing for the Cybersecurity Action took place, and the court entered an order finally approving the settlement and dismissing the action. |
| September 3, 2025 | Company made the first earn out payment for CRMS in the amount of $1,687,134 for an additional 16.3% of equity. |
| September 2025 | FASB issued ASU No. 2025-06, Intangibles Goodwill and Other Internal-Use Software. |
| October 20, 2025 | Holdings acquired 100% of SteadyMD, Inc. |
| October 20, 2025 | Stipulation entered to stay the Hyung action while the Board's committee review proceeds. |
| December 15, 2026 | Effective date for ASU 2024-03 (Expense Disaggregation Disclosures) for fiscal years beginning after this date. |
| December 15, 2026 | Effective date for ASU 2025-03 (Determining Accounting Acquirer in VIEs) for annual periods beginning after this date. |
| December 15, 2027 | Effective date for ASU 2025-06 (Internal-Use Software) for annual periods beginning after this date. |
| February 6, 2026 | Hearing on motion for preliminary approval of the California Labor Actions settlement. |
| January 2026 | Motion to dismiss the consolidated derivative actions due to be fully briefed. |
Recommendation
sellThe company's Q3 2025 results show a severe deterioration in financial performance, with a nearly 50% revenue decline and a substantial net loss, primarily driven by the cessation of high-revenue migrant-related contracts. The recognition of over $16 million in goodwill and intangible asset impairments signals a significant re-evaluation of asset values and future prospects in the Mobile Health Services segment. While the Transportation Services segment shows modest growth, it is insufficient to offset the broader decline. The increased cost of revenues as a percentage of revenue and rising operating expenses (even excluding impairments) indicate margin pressure and operational inefficiencies. The ongoing legal proceedings, while some are settling, still present uncertainties. Given the sharp decline in core revenue, significant losses, and asset write-downs, the short-to-medium term outlook appears challenging, warranting a 'sell' recommendation for investors.
Keywords
Mobile Health Services, Transportation Services, SEC Filing, 10-Q, Financial Results, Net Loss, Revenue Decline, Goodwill Impairment, Intangible Asset Impairment, Migrant Services, Healthcare Transportation, Telehealth, Acquisition, DocGo, DCGO, Quarterly Report, Financial Performance, Risk Factors, Operating Expenses, Cash Flow, Share Repurchase
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.